SIREESHA CHIMATA
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry TALLAHASSEE, FL NPI 1194922286
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry FL Corium, Inc. All categories
General Payments — all program years on this page
$645.52
- Category: General Payments
- Program years: PY2018–2023
- Record count: 27
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $123.37 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $123.37 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $24.33 | 1 |
| Axsome Therapeutics, Inc. | $19.65 | 1 |
| ABBVIE INC. | $19.17 | 1 |
| Vanda Pharmaceuticals Inc. | $17.46 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.96 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.84 | 1 |
| Janssen Pharmaceuticals, Inc | $12.96 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1051521959 | Vanda Pharmaceuticals Inc. | $17.46 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1055368239 | Takeda Pharmaceuticals U.S.A., Inc. | $15.96 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056219055 | Axsome Therapeutics, Inc. | $19.65 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1056918211 | Teva Pharmaceuticals USA, Inc. | $13.84 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 977947455 | Corium, LLC | $24.33 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 987796381 | Janssen Pharmaceuticals, Inc | $12.96 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996423525 | AbbVie Inc. | $19.17 | 08/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.